Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

埃博拉病毒免疫反应失调的分子机制

基本信息

项目摘要

OVERALL: PROJECT SUMMARY/ABSTRACT The central hypothesis of the proposed P01 Program is that Ebola virus infection leads to cell-type specific transcriptional, posttranscriptional, and posttranslational alterations that create aberrant counterproductive responses of immune cells, leading to a dysregulated immune response, which paradoxically produces “immune paralysis” and hyperinflammation. To address the hypothesis, three Research Projects are proposed. Research Project 1 focuses on pathogenic mechanisms at the transcriptional level, while Research Project 2 focuses on posttranscriptional events, and Research Project 3 focuses on posttranslational modifications, each contributing to the dysregulated immune response to Ebola virus. The dysregulated immune response is responsible for most of the pathogenesis observed in Ebola virus disease. All projects require the BSL-4 Core (Core B), which will be responsible for performing infections of human immune and nonimmune cells, nonhuman primates, and the initial steps of experiments that involve infectious virus. Importantly, Core B will provide each of the research projects samples from the same experimental samples insuring that data from each project can be compared directly—this is a unique feature of this P01 Program. The Proteogenomics Core (Core C) will be responsible for massive parallel sequencing and mass spectrometry-based studies. The Bioinformatics and Modeling Core (Core D) is critical for generating tools employed in the experimental designs, including statistical help for OMICS experiments, analyzing OMICS data and integrating OMICS data into networks that model the behavior of various cell populations infected with EBOV. The work done in Core D will synthesize a model to explain how transcriptional, posttranscriptional, and posttranslational responses of individual cell populations lead to immune dysregulation. The comprehensive picture painted by this collaborative effort will revolutionize our understanding of the immunopathogenesis of severe acute viral infections (e.g., immune imbalance seen in COVID-19). The Administrative Core (Core A) will be responsible for strategic planning, continual evaluation, and communication and coordination of activities among the various components of the project according to a detailed management plan. The expected outcomes will contribute substantially to our knowledge of the fundamental mechanisms of the immunopathogenesis of EBOV infections toward the development of effective countermeasures. The expected outcomes will include (1) detailed knowledge of transcriptional mechanisms leading to the dysregulated immune response to EBOV, (2) elucidation of the role of posttranscriptional mechanisms in the dysregulated immune response to EBOV, (3) elucidation of the role of posttranslational mechanisms in the dysregulated immune response to EBOV, and (4) experimental validation of the identified pathogenic mechanisms and their targeting. The proposed tightly coordinated and comprehensive analysis has not been done before for any virus.
总体:项目总结/摘要 拟议的P01计划的中心假设是,埃博拉病毒感染导致细胞类型特异性 转录、转录后和翻译后改变,造成异常的反作用, 免疫细胞的反应,导致免疫反应失调,这矛盾地产生“免疫”。 麻痹”和炎症过度。为了解决这一假设,提出了三个研究项目。研究 项目1侧重于转录水平的致病机制,而研究项目2侧重于 转录后事件,研究项目3侧重于翻译后修饰,每个贡献 与埃博拉病毒免疫反应失调有关免疫反应失调是造成大部分疾病的原因 埃博拉病毒病的发病机制。 所有项目都需要BSL-4核心(核心B),该核心将负责执行人类感染 免疫和非免疫细胞,非人灵长类动物,以及涉及感染性实验的初始步骤, 病毒重要的是,核心B将提供来自同一实验的每个研究项目样本。 样本确保每个项目的数据可以直接进行比较-这是P01的独特功能 程序.蛋白质基因组学核心(Core C)将负责大规模并行测序和质量分析。 基于光谱学的研究生物信息学和建模核心(核心D)对于生成工具至关重要 在实验设计中使用,包括OMICS实验的统计帮助,分析OMICS数据 并将OMICS数据整合到网络中,模拟感染的各种细胞群的行为。 EBOV。核心D中所做的工作将综合一个模型来解释转录,转录后, 单个细胞群的翻译后应答导致免疫失调。综合 这项合作所描绘的画面将彻底改变我们对免疫发病机制的理解。 严重的急性病毒感染(例如,COVID-19中出现的免疫失衡)。核心A(Core A) 负责战略规划、持续评估、沟通和活动协调 根据详细的管理计划,在项目的各个组成部分之间进行协调。 预期的结果将大大有助于我们了解的基本机制, EBOV感染的免疫发病机制朝着制定有效对策的方向发展。预期 结果将包括(1)详细了解导致免疫失调的转录机制, (2)阐明转录后机制在免疫失调中的作用, (3)阐明了翻译后机制在免疫失调中的作用, 对EBOV的应答,以及(4)鉴定的致病机制及其靶向的实验验证。 所提议的紧密协调和全面的分析以前从未对任何病毒进行过。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Next-generation sequencing: A new avenue to understand viral RNA-protein interactions.
The anti-immune dengue subgenomic flaviviral RNA is present in vesicles in mosquito saliva and is associated with increased infectivity.
  • DOI:
    10.1371/journal.ppat.1011224
  • 发表时间:
    2023-03
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
  • 通讯作者:
Early Splicing Complexes and Human Disease.
Role of Alternative Splicing in Regulating Host Response to Viral Infection.
  • DOI:
    10.3390/cells10071720
  • 发表时间:
    2021-07-08
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Liao KC;Garcia-Blanco MA
  • 通讯作者:
    Garcia-Blanco MA
RNA Viruses, Pandemics and Anticipatory Preparedness.
  • DOI:
    10.3390/v14102176
  • 发表时间:
    2022-09-30
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Garcia-Blanco MA;Ooi EE;Sessions OM
  • 通讯作者:
    Sessions OM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander Bukreyev其他文献

Alexander Bukreyev的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander Bukreyev', 18)}}的其他基金

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus
埃博拉病毒免疫反应失调的分子机制
  • 批准号:
    10394314
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Core B: Biosafety Level 4 Core
核心 B:生物安全 4 级核心
  • 批准号:
    10394316
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
研究项目1:表观遗传和转录机制在埃博拉病毒疾病发病机制中的作用
  • 批准号:
    10602491
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10188755
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10602483
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Core B: Biosafety Level 4 Core
核心 B:生物安全 4 级核心
  • 批准号:
    10188756
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
研究项目1:表观遗传和转录机制在埃博拉病毒疾病发病机制中的作用
  • 批准号:
    10188759
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10394315
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
研究项目1:表观遗传和转录机制在埃博拉病毒疾病发病机制中的作用
  • 批准号:
    10394319
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:
Core B: Biosafety Level 4 Core
核心 B:生物安全 4 级核心
  • 批准号:
    10602485
  • 财政年份:
    2021
  • 资助金额:
    $ 221.31万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 221.31万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了